Considering the impact of liraglutide on neutrophil activation and the critical roles of neutrophils in cancer prognosis [51], we further analyzed the important circulating molecules released by neutrophils, finding that liraglutide decreased NETs markers myeloperoxidase, elastase, and dsDNA in both tumor models. Here, MPO is linked to neoplasm.